OpenVSafe by OpenVAERS
Search V-safe

Y6G-23477-67405

3 vaccinations 4 coded responses 26 check-ins 4 free-text entries 1 call case
Sex
Male
Age at first dose
61-65
ZIP prefix
787 / TX
Registered
2021-03-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-20
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-21
    Registered in v-safe
  3. 2021-03-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vaccination site pain — Feeling: Good
    Free text: Typical post vaccination localized soreness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Respiratory tract congestion — Feeling: Fair
    Free text: Slight congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-10
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-17
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-17
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-24
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-05-01
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-15
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-29
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-17
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-10-16
    Survey response — 6 months, dose 2
    MedDRA: Diarrhoea, Office visit, Weight decreased — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Diarrhea since 23AUG21; under care of GP; appt. w/ Gastroenterologist 26OCT21. Some weight loss; appetite good; overall health otherwise is excellent; no other COVID related symptoms.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-10-16
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  28. 2021-10-20
  29. 2021-10-28
    Dose 3 — Pfizer-BioNTech
    Co-administered: Tetanus
  30. 2022-04-17
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  31. 2022-04-28
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-10-28
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Cough, Nasal congestion, Productive cough, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Contracted COVID variant Omicron BA.5 post trip home from UK 7/12/2022. Returned from a subsequent trip to UK 10/12/2022 with similar symptoms- did not test. Severe chest and nasal congestion; dry cough; productive cough post 4 days; no fever.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-20Pfizer-BioNTech
22021-04-17Pfizer-BioNTech
32021-10-28Pfizer-BioNTech Tetanus

Call center

ReportedOutcomeVAERS-related outcome
2021-10-16 Unsuccessful

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-21

Systemic reaction (other): Typical post vaccination localized soreness

2021-03-24

Systemic reaction (other): Slight congestion

Release 10 — 6 months, dose 2

2021-10-16

Symptoms: Diarrhea since 23AUG21; under care of GP; appt. w/ Gastroenterologist 26OCT21. Some weight loss; appetite good; overall health otherwise is excellent; no other COVID related symptoms.

Release 12 — 12 months, dose 3

2022-10-28

Symptoms: Contracted COVID variant Omicron BA.5 post trip home from UK 7/12/2022. Returned from a subsequent trip to UK 10/12/2022 with similar symptoms- did not test. Severe chest and nasal congestion; dry cough; productive cough post 4 days; no fever.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDCOVID-19 · · ✓
SDDiarrhoea · · ✓
SDNasal congestion · · ✓
SDOffice visit · · ✓
SDProductive cough · · ✓
SDRespiratory tract congestion · · ✓
SDWeight decreased · · ✓
SRORespiratory tract congestion ✓ ✓ ✓
SROVaccination site pain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…